They found a total of 544 articles, but once duplicate articles were taken out, only 36 studies remained
And heres the thing that shocked me most about this
Inequalities in oral health practices and social space: an exploratory qualitative study
Additional well-designed, prospective studies are needed to confirm the potential benefit of GLP-1 receptor agonist treatment for patients with advanced CKD or ESKD." For further information: DOI: 10.1001/jamanetworkopen.2022.1169 Keywords: CKD, ESKD, GLP-1 receptor agonist, DPP-4 inhibitors, type 2 diabetes, JAMA Network Open, chronic kidney disease, end-stage kidney disease, National Health Insurance Research Database of Taiwan, MACCE, Mortality rate
She may change your plan so you get better results and have fewer side effects
Para continuar, acessesua conta trace-id: 52fbbf60-cdda-4f55-996b-3dfc39f8079f Usamos cookies para melhorar sua experincia no Mercado Livre